Nearly 20% of patients with type 2 diabetes do not benefit from exercise
the ONA take:
According to a new study published in the Journal of Clinical Endocrinology & Metabolism, one in five people with type 2 diabetes mellitus do not achieve any improvement in blood sugar control when they participate in a supervised exercise regimen.
For the study, researchers analyzed data from clinical studies that investigated the use of exercise regimens in patients with type 2 diabetes. They also looked at animal and genetic studies that did the same. Results showed that about 15 to 20% of patients with type 2 diabetes did not experience improvement in blood sugar control, insulin sensitivity, or muscle mitochondrial density.
The animal and genetic studies suggest that the resistance to exercise is genetic and can be passed from one generation to the next.
The U.S. Centers for Disease Control and Prevention estimates that about 40% of American will develop type 2 diabetes in their lifetime. Because obesity and lack of exercise are associated with the disease, exercise is often recommended to patients with diabetes to help manage the disease.
This study shows that while most people benefit from exercise, nearly 20% of patients with type 2 diabetes do not as a result of their DNA.
One in five people with type 2 diabetes mellitus do not achieve any improvement in blood sugar control.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|